Could a monthly Sublocade injection offer a different approach to opioid addiction treatment than taking medication every day? For Knoxville adults managing opioid dependence, choosing between injectable buprenorphine and daily Suboxone involves understanding the benefits, potential risks, and long-term treatment options. Learn how these prescription medications compare, who may qualify, and what to discuss with your healthcare provider before starting a treatment plan.
What Is Sublocade Injection and How Does It Work?
Sublocade injection is a monthly, extended-release buprenorphine medication used to treat moderate to severe opioid use disorder in adults. Its active ingredient, buprenorphine, is a partial opioid agonist that binds to opioid receptors in the brain, reducing opioid cravings and withdrawal symptoms while limiting the effects of other opioids. A healthcare professional administers the injection under the skin of the abdomen, where the medication gradually releases buprenorphine for several weeks after each monthly injection to support long-term addiction recovery.
Who Qualifies for Sublocade Treatment?
Sublocade treatment is approved for adults with moderate to severe opioid use disorder who have started treatment with a buprenorphine-containing medication. Patients may qualify after receiving a single dose of transmucosal buprenorphine to confirm tolerability or after already taking buprenorphine for opioid addiction. A healthcare provider evaluates opioid use history, withdrawal symptoms, medical conditions, and treatment goals to determine eligibility.
Sublocade Injection vs. Daily Suboxone for Opioid Use Disorder
Sublocade and Suboxone are both brand-name drugs that share buprenorphine as the active ingredient, which helps reduce opioid cravings and withdrawal symptoms. Sublocade provides a monthly injection administered by a healthcare professional, while Suboxone is available as a daily sublingual film or tablet containing buprenorphine and naloxone. Sublocade eliminates daily dosing and may improve medication adherence, while Suboxone offers greater flexibility for dose adjustments and at-home treatment, so these options may work better for different patients depending on the treatment plan.
Benefits of Sublocade for Opioid Addiction Recovery
Sublocade provides steady buprenorphine levels throughout the month, helping patients manage opioid dependence, prevent withdrawal symptoms, and maintain recovery. Potential benefits include:
- Reduced opioid cravings and withdrawal symptoms
- Monthly injections instead of daily medication
- Consistent medication delivery throughout treatment
- Reduced risk of missed daily doses
- Lower risk of medication misuse or diversion because clinician administration reduces risks tied to drug abuse
- Improved treatment adherence for some patients
- Greater convenience for work and daily responsibilities
- Support for long-term opioid addiction recovery
Sublocade vs. Brixadi and Other Buprenorphine Treatments
Sublocade and Brixadi are extended-release buprenorphine injections used to treat opioid use disorder. Sublocade is administered monthly, while Brixadi offers weekly and monthly injections with different dosing options. Other treatments, including Suboxone and generic buprenorphine tablets or films, require more frequent dosing but may provide greater flexibility during medication adjustments.
Sublocade Dosage and Monthly Injection Schedule
The standard Sublocade dosage begins with 300 mg injections for the first two months, followed by a recommended maintenance dose of 100 mg monthly. Healthcare providers may continue or return to 300 mg maintenance doses when patients need additional symptom control and can tolerate the medication. Injections are generally scheduled at least 26 days apart, and dosage adjustments depend on treatment response, opioid cravings, and side effects. If you miss a scheduled dose, follow-up timing should be handled as your doctor tells you.
How Is Sublocade Injection Administered and What Should Patients Expect?
Sublocade is prescribed and administered by a qualified healthcare provider as a subcutaneous injection into the abdomen, thigh, buttock, or back of the upper arm, and it is not self administered. It is available only through a restricted distribution program because of safety risks. The medication forms a small depot beneath the skin that gradually releases buprenorphine, and patients may notice a temporary lump or mild discomfort at the injection site. Patients typically return every month for another injection and follow-up appointments to monitor cravings, withdrawal symptoms, and recovery progress.
How Long Does Sublocade Stay in Your System?
Sublocade releases buprenorphine over approximately one month, but the medication can remain in the body long after the final injection. Due to its extended-release formulation, buprenorphine may remain detectable in blood or urine for 12 months or longer after stopping treatment, depending on treatment duration and individual factors. Withdrawal symptoms may also develop weeks or months after the last injection as medication levels gradually decline.
Prevalence of Sublocade Treatment for Opioid Addiction
Opioid use disorder affects millions of Americans, creating a growing need for medications such as Sublocade, Suboxone, and methadone. According to the 2023 National Survey on Drug Use and Health, approximately 5.7 million people aged 12 or older experienced opioid use disorder in the past year. Although monthly buprenorphine injections provide another treatment option, national statistics do not consistently report how many patients specifically receive Sublocade compared with other medications for opioid use disorder.
Effects and Risks of Sublocade Injection
**Short-Term**:
- Injection-site pain, swelling, or itching
- Nausea and vomiting
- Constipation
- Headaches
- Dizziness and fatigue
- Drowsiness or sedation
- Precipitated opioid withdrawal if treatment begins too soon
**Long-Term**:
- Physical dependence on buprenorphine
- Delayed withdrawal symptoms after stopping treatment
- Liver problems or elevated liver enzymes
- Hormonal changes with prolonged opioid exposure
- Persistent constipation
- Serious breathing problems when combined with sedatives
- Overdose risk from additional opioid or sedative use
Sublocade may affect the adrenal gland and sexual desire, while opioid exposure during pregnancy can cause neonatal opioid withdrawal syndrome, with symptoms such as a high-pitched cry and runny nose that may require emergency treatment.
How Effective Is Sublocade at Preventing Opioid Cravings and Relapse?
Sublocade helps reduce cravings and withdrawal symptoms associated with heroin, fentanyl, oxycodone, hydrocodone, morphine, and other opioids. In a 24-week clinical trial, approximately 42% of patients receiving monthly Sublocade met the study's opioid-use abstinence endpoint, compared with 5% receiving placebo. Sublocade can reduce illicit opioid use and support relapse prevention, but it does not eliminate cravings or guarantee protection against relapse.
Sublocade Withdrawal Symptoms and Missed Injections
Sublocade withdrawal symptoms may include anxiety, restlessness, sweating, nausea, muscle aches, insomnia, opioid cravings, a fast heartbeat, and stomach cramps. Because buprenorphine leaves the body slowly, patients may experience withdrawal symptoms a month or more after the last injection rather than immediately. Patients who miss an injection should contact their healthcare provider to reschedule, as longer delays may require reassessment before treatment continues.
Can Sublocade Help Reduce the Risk of Opioid Overdose?
Sublocade may reduce opioid overdose risk by helping patients avoid illicit opioids, including heroin and fentanyl, and maintain treatment for opioid use disorder. However, Sublocade does not completely block other opioids, and overdose remains possible, especially when combined with alcohol, benzodiazepines, or other sedatives. Patients should keep naloxone available and understand that returning to opioid use after stopping treatment can increase overdose risk because opioid tolerance may decrease.
Sublocade for Fentanyl and Prescription Opioid Addiction
Sublocade treats opioid use disorder involving opioid drugs such as fentanyl, heroin, and prescription painkillers such as oxycodone, hydrocodone, morphine, and codeine. Its extended-release buprenorphine formulation helps control cravings and withdrawal symptoms without requiring daily medication. People who regularly use fentanyl may need additional monitoring when starting buprenorphine because fentanyl exposure can complicate withdrawal and increase the risk of precipitated withdrawal.
Sublocade and Co-Occurring Mental Health Disorders
People with opioid use disorder may also experience depression, generalized anxiety disorder, post-traumatic stress disorder (PTSD), bipolar disorder, panic disorder, or attention-deficit/hyperactivity disorder (ADHD). These conditions can increase emotional distress, interfere with treatment, and contribute to substance use as a way to manage symptoms. Sublocade treats opioid dependence rather than mental health disorders, so patients may also benefit from psychiatric care, behavioral therapy, and appropriate mental health medications.
How Long Does Sublocade Treatment Last and What Happens When You Stop?
Sublocade treatment has no fixed maximum duration, and some patients continue monthly injections for several months or years based on their recovery needs. Healthcare providers consider opioid cravings, relapse history, treatment progress, and patient preferences before recommending discontinuation. After stopping Sublocade, buprenorphine levels decline gradually, and patients may experience delayed withdrawal symptoms or increased cravings that require continued monitoring. Some patients can develop severe withdrawal after stopping treatment, and delayed symptoms may appear a month or longer after the last injection, so ongoing monitoring is important.
Sublocade Drug Interactions and Safety Precautions
Sublocade can interact with alcohol, benzodiazepines like Xanax and Valium, sleep medications, muscle relaxants, and opioids, increasing sedation, respiratory depression, and overdose risks. Certain antibiotics, antifungals, seizure medications, and HIV treatments may alter buprenorphine levels. Patients should keep a list of prescription and over the counter medications, review the Medication Guide, and disclose liver problems, brain tumors, adrenal insufficiency, or planned dental surgery.
Patients taking Sublocade or sublingual buprenorphine should seek immediate medical attention for an allergic reaction, trouble breathing, shallow breathing, slow heartbeat, or irregular heartbeat. Even at average doses, contact your doctor immediately for the following symptoms: dizziness or fainting when rising from a lying position.
Combining Sublocade With Behavioral Therapy, Medication Assisted Treatment, and Outpatient Treatment
Sublocade can be combined with cognitive behavioral therapy (CBT), individual counseling, group therapy, relapse prevention, and intensive outpatient programs (IOPs). These services help patients identify substance use triggers, manage stress, develop coping skills, and address co-occurring mental health conditions. Combining medication management with behavioral health services can support long-term recovery while allowing many patients to maintain work, school, and family responsibilities.
What to Expect From Your Sublocade Treatment Plan
A Sublocade treatment plan uses monthly extended-release buprenorphine injections to control opioid cravings and support recovery without daily medication. Common side effects include nausea, constipation, headaches, and injection-site discomfort, but severe reactions require medical attention. Contact your doctor immediately if you experience trouble breathing, severe dizziness, or signs of an allergic reaction.
When to Seek Help
People experiencing persistent opioid cravings, withdrawal symptoms, repeated relapse, or difficulty controlling fentanyl, heroin, or prescription opioid use should seek professional treatment. Warning signs include increasing tolerance, continued substance use despite consequences, and worsening depression or anxiety. A healthcare provider can determine whether Sublocade or another opioid addiction treatment is appropriate.
Sublocade Injection Treatment Options
Sublocade can be combined with different levels of addiction treatment based on individual needs.
- **Medication-Assisted Treatment (MAT):** Uses medications such as Sublocade to manage opioid cravings and withdrawal.
- **Medical Detoxification:** Provides supervised withdrawal management and preparation for ongoing treatment.
- **Intensive Outpatient Programs (IOP):** Offer structured therapy and relapse prevention while patients live at home.
- **Partial Hospitalization Programs (PHP)****:** Provide intensive daytime treatment without overnight stays.
- **Residential Treatment:** Offers structured addiction treatment with 24-hour residential support.
- **Outpatient Treatment:** Includes counseling, medication management, and recovery monitoring.
- **Dual Diagnosis Treatment****:** Addresses opioid addiction alongside depression, anxiety, PTSD, and other mental health disorders.
Does Insurance Cover Treatment?
Many private insurance plans, Medicare, and Medicaid programs may cover Sublocade when medically necessary. In Tennessee, TennCare coverage depends on eligibility, provider participation, and plan requirements. Patients should verify medication costs, injection fees, and outpatient treatment benefits before starting care.
Conclusion
Sublocade injection offers a monthly maintenance treatment option for opioid use disorder, but the best treatment depends on individual health needs, medication history, and recovery goals. Patients should review common side effects, missed doses, liver disease, breathing conditions such as chronic obstructive pulmonary disease, and other potential risks with their doctor. With appropriate medication management, lifestyle changes, and ongoing support, people in Knoxville can work toward sustained recovery from opioid addiction.
Seeking Treatment? We Can Help!
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
FAQs
Is Sublocade Better Than Suboxone?
Sublocade offers monthly injections, while Suboxone requires daily dosing. Both treat opioid use disorder, but the better option depends on individual treatment needs.
Does Sublocade Cause Weight Gain?
Weight gain is not a common reported side effect of Sublocade. However, changes in appetite, activity, and overall health during recovery may affect weight.
Can You Drink Alcohol While Taking Sublocade?
No. Alcohol can increase the risk of severe sedation, breathing problems, overdose, and death when combined with Sublocade.
People Also Ask
How Long Does One Sublocade Injection Last?
Each Sublocade injection releases buprenorphine over approximately one month. The medication can remain detectable in the body for months after the last injection.
What Are the Disadvantages of Sublocade?
Disadvantages include injection-site reactions, possible withdrawal symptoms, medication interactions, and the need for monthly healthcare visits.
Can You Still Get High While Taking Sublocade?
Yes. Sublocade reduces the effects of other opioids but does not completely block them. Using opioids during treatment can still cause a fatal overdose.
Sources